These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4998538)

  • 1. Absorption, excretion, and biotransformation of procainamide-C 14 in the dog and rhesus monkey.
    Dreyfuss J; Ross JJ; Schreiber EC
    Arzneimittelforschung; 1971 Jul; 21(7):948-51. PubMed ID: 4998538
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of procainamide in rhesus monkey and man.
    Dreyfuss J; Bigger JT; Cohen AI; Schreiber EC
    Clin Pharmacol Ther; 1972; 13(3):366-71. PubMed ID: 4623713
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of procainamide.
    Weily HS; Genton E
    Arch Intern Med; 1972 Sep; 130(3):366-9. PubMed ID: 5055693
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.
    Hayes A; Cooper RG
    J Pharmacol Exp Ther; 1971 Feb; 176(2):302-11. PubMed ID: 4998689
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.
    Lan SJ; Chando TJ; Weliky I; Schreiber EC
    J Pharmacol Exp Ther; 1973 Aug; 186(2):323-30. PubMed ID: 4719785
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic transport of mono bisquaternary ammonium compounds.
    Meijer DK; Bos ES; van der Laan KJ
    Eur J Pharmacol; 1970; 11(3):371-7. PubMed ID: 5477311
    [No Abstract]   [Full Text] [Related]  

  • 7. Species differences in the physiological disposition of 3-tritylthio-L-alanine (NSC83265).
    Coffey JJ; Palm PE; Denine EP; Baronowsky PE; Kensler CJ
    Cancer Res; 1971 Dec; 31(12):1908-14. PubMed ID: 5000977
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological disposition and metabolic fate of fluphenazine- 14 C in the dog and rhesus monkey.
    Dreyfuss J; Ross JJ; Schreiber EC
    J Pharm Sci; 1971 Jun; 60(6):821-5. PubMed ID: 5001926
    [No Abstract]   [Full Text] [Related]  

  • 9. Thin-layer chromatographic determination of procainamide and N-acetylprocainamide in human serum and urine at single-dose levels.
    Kark B; Sistovaris N; Keller A
    J Chromatogr; 1983 Oct; 277():261-72. PubMed ID: 6196373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species difference in the plasma disappearance and biliary excretion of procaine amide ethobromide.
    Hunter A; Klaassen CD; Doull J
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1445-50. PubMed ID: 5023345
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution, biotransformation and excretion of bupivacaine in the rat and the monkey.
    Goehl TJ; Davenport JB; Stanley MJ
    Xenobiotica; 1973 Dec; 3(12):761-72. PubMed ID: 4206825
    [No Abstract]   [Full Text] [Related]  

  • 12. The reversible biotransformation of N-acetylprocainamide in the rhesus monkey.
    Ding TL; Lin ET; Benet LZ
    Arzneimittelforschung; 1978; 28(2):281-3. PubMed ID: 416831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absorption, distribution, excretion, and biotransformation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in animals.
    Oliverio VT; Vietzke WM; Williams MK; Adamson RH
    Cancer Res; 1970 May; 30(5):1330-7. PubMed ID: 4987693
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotransformation of diphenoxylate in rat and dog.
    Karim A; Garden G; Trager W
    J Pharmacol Exp Ther; 1971 Jun; 177(3):546-55. PubMed ID: 5568810
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and biotransformation of chlorpropamide in the rat and dog.
    Taylor JA
    Drug Metab Dispos; 1974; 2(3):221-7. PubMed ID: 4152995
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of procainamide in normal and cardiac subjects.
    Giardina EG; Dreyfuss J; Bigger JT; Shaw JM; Schreiber EC
    Clin Pharmacol Ther; 1976 Mar; 19(3):339-51. PubMed ID: 1261169
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-(glutathion-S-yl)acetaminophen: a biliary metabolite of acetaminophen.
    Hinson JA; Monks TJ; Hong M; Highet RJ; Pohl LR
    Drug Metab Dispos; 1982; 10(1):47-50. PubMed ID: 6124382
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of demoxepam, a chlordiazepoxide metabolite, in the dog.
    Schwartz MA; Postma E; Kolis SJ
    J Pharm Sci; 1971 Mar; 60(3):438-44. PubMed ID: 5572124
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man.
    Hucker HB; Grady LT; Michniewicz BM; Stauffer SC; White SE; Maha GE; McMahon FG
    J Pharmacol Exp Ther; 1971 Nov; 179(2):359-71. PubMed ID: 5002483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.